vs
Side-by-side financial comparison of HANMI FINANCIAL CORP (HAFC) and IRONWOOD PHARMACEUTICALS INC (IRWD). Click either name above to swap in a different company.
HANMI FINANCIAL CORP is the larger business by last-quarter revenue ($71.2M vs $47.7M, roughly 1.5× IRONWOOD PHARMACEUTICALS INC). HANMI FINANCIAL CORP runs the higher net margin — 29.8% vs -4.8%, a 34.6% gap on every dollar of revenue. On growth, HANMI FINANCIAL CORP posted the faster year-over-year revenue change (17.1% vs -47.3%). HANMI FINANCIAL CORP produced more free cash flow last quarter ($203.7M vs $74.6M). Over the past eight quarters, HANMI FINANCIAL CORP's revenue compounded faster (10.4% CAGR vs -20.2%).
Hanmi Bank Corporation is a community bank headquartered in Los Angeles, California, with 35 branches and eight loan production offices in California, Texas, Illinois, New York, New Jersey and Virginia.
Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.
HAFC vs IRWD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $71.2M | $47.7M |
| Net Profit | $21.2M | $-2.3M |
| Gross Margin | — | — |
| Operating Margin | 29.8% | 14.3% |
| Net Margin | 29.8% | -4.8% |
| Revenue YoY | 17.1% | -47.3% |
| Net Profit YoY | 20.0% | -200.9% |
| EPS (diluted) | $0.70 | $0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $71.2M | $47.7M | ||
| Q3 25 | $71.0M | $122.1M | ||
| Q2 25 | $65.2M | $85.2M | ||
| Q1 25 | $62.8M | $41.1M | ||
| Q4 24 | $60.8M | $90.5M | ||
| Q3 24 | $58.5M | $91.6M | ||
| Q2 24 | $56.7M | $94.4M | ||
| Q1 24 | $58.4M | $74.9M |
| Q4 25 | $21.2M | $-2.3M | ||
| Q3 25 | $22.1M | $40.1M | ||
| Q2 25 | $15.1M | $23.6M | ||
| Q1 25 | $17.7M | $-37.4M | ||
| Q4 24 | $17.7M | $2.3M | ||
| Q3 24 | $14.9M | $3.6M | ||
| Q2 24 | $14.5M | $-860.0K | ||
| Q1 24 | $15.2M | $-4.2M |
| Q4 25 | 29.8% | 14.3% | ||
| Q3 25 | 31.1% | 61.8% | ||
| Q2 25 | 23.2% | 53.2% | ||
| Q1 25 | 28.1% | -70.7% | ||
| Q4 24 | 29.1% | 34.8% | ||
| Q3 24 | 25.5% | 28.0% | ||
| Q2 24 | 25.5% | 26.5% | ||
| Q1 24 | 26.0% | 14.7% |
| Q4 25 | 29.8% | -4.8% | ||
| Q3 25 | 31.1% | 32.8% | ||
| Q2 25 | 23.2% | 27.7% | ||
| Q1 25 | 28.1% | -90.9% | ||
| Q4 24 | 29.1% | 2.5% | ||
| Q3 24 | 25.5% | 4.0% | ||
| Q2 24 | 25.5% | -0.9% | ||
| Q1 24 | 26.0% | -5.6% |
| Q4 25 | $0.70 | $0.01 | ||
| Q3 25 | $0.73 | $0.23 | ||
| Q2 25 | $0.50 | $0.14 | ||
| Q1 25 | $0.58 | $-0.23 | ||
| Q4 24 | $0.58 | $0.03 | ||
| Q3 24 | $0.49 | $0.02 | ||
| Q2 24 | $0.48 | $-0.01 | ||
| Q1 24 | $0.50 | $-0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $215.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $796.4M | $-261.8M |
| Total Assets | $7.9B | $396.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $215.5M | ||
| Q3 25 | — | $140.4M | ||
| Q2 25 | — | $92.9M | ||
| Q1 25 | — | $108.5M | ||
| Q4 24 | — | $88.6M | ||
| Q3 24 | — | $88.2M | ||
| Q2 24 | — | $105.5M | ||
| Q1 24 | — | $121.5M |
| Q4 25 | — | — | ||
| Q3 25 | — | $199.5M | ||
| Q2 25 | — | $199.3M | ||
| Q1 25 | — | $199.2M | ||
| Q4 24 | — | $199.0M | ||
| Q3 24 | — | $198.8M | ||
| Q2 24 | — | $198.6M | ||
| Q1 24 | — | $398.3M |
| Q4 25 | $796.4M | $-261.8M | ||
| Q3 25 | $779.5M | $-264.2M | ||
| Q2 25 | $762.8M | $-308.2M | ||
| Q1 25 | $751.5M | $-334.1M | ||
| Q4 24 | $732.2M | $-301.3M | ||
| Q3 24 | $736.7M | $-311.3M | ||
| Q2 24 | $707.1M | $-321.7M | ||
| Q1 24 | $703.1M | $-330.5M |
| Q4 25 | $7.9B | $396.9M | ||
| Q3 25 | $7.9B | $396.1M | ||
| Q2 25 | $7.9B | $342.9M | ||
| Q1 25 | $7.7B | $327.2M | ||
| Q4 24 | $7.7B | $350.9M | ||
| Q3 24 | $7.7B | $389.5M | ||
| Q2 24 | $7.6B | $395.6M | ||
| Q1 24 | $7.5B | $438.8M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $206.0M | $74.6M |
| Free Cash FlowOCF − Capex | $203.7M | $74.6M |
| FCF MarginFCF / Revenue | 286.2% | 156.3% |
| Capex IntensityCapex / Revenue | 3.2% | 0.0% |
| Cash ConversionOCF / Net Profit | 9.70× | — |
| TTM Free Cash FlowTrailing 4 quarters | $356.1M | $127.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $206.0M | $74.6M | ||
| Q3 25 | $146.9M | $47.6M | ||
| Q2 25 | $-19.0M | $-15.1M | ||
| Q1 25 | $25.8M | $20.0M | ||
| Q4 24 | $52.6M | $15.2M | ||
| Q3 24 | $6.7M | $9.9M | ||
| Q2 24 | $2.1M | $33.5M | ||
| Q1 24 | $30.0M | $45.0M |
| Q4 25 | $203.7M | $74.6M | ||
| Q3 25 | $146.4M | $47.6M | ||
| Q2 25 | $-19.6M | $-15.1M | ||
| Q1 25 | $25.6M | $19.9M | ||
| Q4 24 | $49.9M | — | ||
| Q3 24 | $6.5M | $9.9M | ||
| Q2 24 | $1.3M | $33.4M | ||
| Q1 24 | $29.2M | $44.9M |
| Q4 25 | 286.2% | 156.3% | ||
| Q3 25 | 206.3% | 39.0% | ||
| Q2 25 | -30.0% | -17.7% | ||
| Q1 25 | 40.7% | 48.4% | ||
| Q4 24 | 82.1% | — | ||
| Q3 24 | 11.1% | 10.8% | ||
| Q2 24 | 2.3% | 35.4% | ||
| Q1 24 | 50.0% | 60.0% |
| Q4 25 | 3.2% | 0.0% | ||
| Q3 25 | 0.8% | 0.0% | ||
| Q2 25 | 0.9% | 0.0% | ||
| Q1 25 | 0.4% | 0.1% | ||
| Q4 24 | 4.3% | 0.0% | ||
| Q3 24 | 0.4% | 0.0% | ||
| Q2 24 | 1.4% | 0.1% | ||
| Q1 24 | 1.4% | 0.1% |
| Q4 25 | 9.70× | — | ||
| Q3 25 | 6.66× | 1.19× | ||
| Q2 25 | -1.26× | -0.64× | ||
| Q1 25 | 1.46× | — | ||
| Q4 24 | 2.97× | 6.74× | ||
| Q3 24 | 0.45× | 2.71× | ||
| Q2 24 | 0.14× | — | ||
| Q1 24 | 1.98× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
